 Hui Zhang
Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 9 | 2020 | 1744 | 1.090 |
Why?
| | Polypyrimidine Tract-Binding Protein | 3 | 2017 | 14 | 0.770 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 19 | 0.740 |
Why?
| | Pyruvate Kinase | 2 | 2017 | 20 | 0.740 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 352 | 0.570 |
Why?
| | MicroRNAs | 3 | 2017 | 604 | 0.550 |
Why?
| | Fibroblasts | 4 | 2020 | 839 | 0.410 |
Why?
| | Cell Proliferation | 5 | 2020 | 2192 | 0.230 |
Why?
| | Glycolysis | 4 | 2017 | 227 | 0.230 |
Why?
| | Vascular Remodeling | 3 | 2020 | 154 | 0.220 |
Why?
| | Hypoxia | 4 | 2020 | 959 | 0.190 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 236 | 0.190 |
Why?
| | Antagomirs | 2 | 2017 | 13 | 0.190 |
Why?
| | Pulmonary Artery | 4 | 2020 | 1032 | 0.180 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2020 | 417 | 0.180 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2020 | 37 | 0.170 |
Why?
| | Cattle | 3 | 2017 | 925 | 0.170 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2020 | 82 | 0.170 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2017 | 191 | 0.170 |
Why?
| | RNA Interference | 2 | 2017 | 437 | 0.160 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 225 | 0.150 |
Why?
| | Signal Transduction | 4 | 2019 | 4527 | 0.150 |
Why?
| | Naphthoquinones | 1 | 2017 | 17 | 0.150 |
Why?
| | Animals | 10 | 2020 | 31884 | 0.140 |
Why?
| | Complement Activation | 1 | 2020 | 340 | 0.140 |
Why?
| | Transcriptional Activation | 1 | 2018 | 337 | 0.140 |
Why?
| | Protein Isoforms | 1 | 2017 | 339 | 0.130 |
Why?
| | Macrophages | 3 | 2017 | 1267 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2017 | 188 | 0.130 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 198 | 0.130 |
Why?
| | Immunoglobulin G | 1 | 2020 | 775 | 0.130 |
Why?
| | DNA Methylation | 1 | 2020 | 496 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2016 | 84 | 0.130 |
Why?
| | Interleukin-1beta | 1 | 2017 | 370 | 0.120 |
Why?
| | Energy Metabolism | 2 | 2017 | 730 | 0.120 |
Why?
| | Mitochondria | 2 | 2017 | 750 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2019 | 4718 | 0.110 |
Why?
| | RNA, Messenger | 1 | 2020 | 2563 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 850 | 0.090 |
Why?
| | Mice | 4 | 2020 | 14934 | 0.090 |
Why?
| | Rats | 4 | 2020 | 4980 | 0.080 |
Why?
| | Phenotype | 4 | 2020 | 2814 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 866 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3547 | 0.060 |
Why?
| | Humans | 8 | 2020 | 115219 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2020 | 2586 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2019 | 686 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2017 | 926 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2019 | 3897 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2330 | 0.050 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2020 | 11 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 73 | 0.040 |
Why?
| | Immunoglobulins | 1 | 2020 | 143 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 140 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2019 | 142 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 100 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 114 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 189 | 0.040 |
Why?
| | Lim Kinases | 1 | 2017 | 5 | 0.040 |
Why?
| | Smad5 Protein | 1 | 2017 | 7 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2017 | 18 | 0.040 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 155 | 0.040 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 48 | 0.040 |
Why?
| | Symporters | 1 | 2017 | 52 | 0.040 |
Why?
| | Up-Regulation | 1 | 2020 | 812 | 0.030 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2016 | 8 | 0.030 |
Why?
| | Inflammation | 2 | 2020 | 2485 | 0.030 |
Why?
| | Citric Acid Cycle | 1 | 2016 | 43 | 0.030 |
Why?
| | Cell Respiration | 1 | 2016 | 74 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2016 | 33 | 0.030 |
Why?
| | Pyruvic Acid | 1 | 2016 | 42 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2016 | 56 | 0.030 |
Why?
| | Lung | 2 | 2020 | 3595 | 0.030 |
Why?
| | Superoxides | 1 | 2016 | 214 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 156 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 541 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1424 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2216 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 524 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 598 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 69 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 105 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 59 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 107 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 133 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 171 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2013 | 369 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1086 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3336 | 0.020 |
Why?
| | Histone Deacetylases | 1 | 2013 | 196 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1593 | 0.020 |
Why?
| | Male | 3 | 2020 | 55811 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1898 | 0.020 |
Why?
| | Female | 3 | 2020 | 59717 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1317 | 0.020 |
Why?
| | Adult | 1 | 2013 | 30708 | 0.010 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|